New immunotherapy trial for advanced sarcoma: Researchers at the University of Texas MD Anderson…

MedMaven

New immunotherapy trial for advanced sarcoma: Researchers at the University of Texas MD Anderson Cancer Center, Houston, are conducting a trial to evaluate neoadjuvant checkpoint blockade in patients with surgically resectable soft tissue sarcoma (ClinicalTrials.org Identifier: NCT03307616). The study is evaluating neoadjuvant nivolumab and ipilimumab in combination plus concurrent neoadjuvant radiation therapy

Comments (3)
No. 1-2
Wrip
Wrip

This is important information

Wrip
Wrip

Thank you!


Sarcoma

FEATURED
COMMUNITY